ABOUT US

Perpetua (Italian for “Perpetual”) Life® Biotech is a U.S.-based company focused on research and development in the fields of healthy ageing, mitochondrial biology, and longevity science.

We are a team of scientists, medical professionals, and biotech entrepreneurs committed to advancing evidence-informed approaches to long-term health. Our work centres on identifying promising compounds, analysing emerging research, and translating scientific insights into carefully formulated nutraceutical products.

Our mission is simple: to support longer, healthier lives by bridging cutting-edge longevity research with accessible, high-quality supplementation.

We believe the future of healthy ageing lies at the intersection of cellular biology, metabolic science, and responsible innovation — and we are committed to contributing to that future with integrity and scientific rigour.

Medical Advisory Board + Strategic Partners

  • Dr. Mark Chavez MD

    David Geffen School of Medicine at UCLA

    Dr. Chavez is a medical doctor, health coach, and entrepreneur who is passionate about health, medicine, longevity, and entrepreneurship.

    For over 10 years he has focused his efforts on creating innovative ways to keep people healthy while helping them pursue their passions.

    He is a David Geffen School of Medicine at UCLA alumni.

    Dr. Chavez is the Inventor of The Gravity Ball Method of Grip-Free Resistance Exercise, and the author of the book "The 5 Habits of Healthy People."

  • Prof. Leonas Valius MD, PhD

    Chairman, Dept. Family Medicine at LUHS

    Prof. Valius is a medical doctor and scientist, Chairman of the Dept. of Family Medicine at LUHS, Editor-in-Chief of the peer-reviewed scientific journal Index Copernicus, member of the Board of the European Region of WONCA and EUROPREV, and an LSMU MA Faculty of Medicine council member.


    Prof. Valius has authored countless scientific research papers and has received more accolades than we have space to list in a short bio.

  • Dr. Oscar Segurado MD, PhD

    Chief Medical Officer at ASC Therapeutics

    Dr. Segurado is a medical doctor, scientist, and tenured professor of Immunology living in the San Francisco Bay area with decades of experience in neuroscience and immunology and over 100 scientific and news articles published in top-rated journals like Nature and Lancet.


    Dr. Segurado is a volunteer board member, and the author of the bestseller: "Mindful Framing."

  • Dr. Silvija Valdonė Alšauskė MD

    MD, and PhD candidate at LUHS

    Dr. Alšauskė is a medical doctor, and a PhD candidate doing her thesis on cognitive function and early detection of cognitive function decline in patients with multimorbidity (in primary care setting).
    She is also the founder of Egomedum.

  • Prof. Ted Katagi MBA

    Berkeley, Harvard Business School

    Ted Katagi is the co-founder and CEO of Kenja, a Council Leader of the US-Japan Council, Chair of the Marketing and Public Relations Leadership of the American Chamber of Commerce Japan (ACCJ), an ambassador of the Global Business Blockchain Council, as well as a professor at the University of Tsukuba.

    He is a University of California, Berkeley and Harvard Business School alumni.


    Prof. Katagi is a strategic advisor and is assisting in distribution of Perpetua.Life® products in Asia.

OUR STORY

Perpetua Life® began in 2017 in the O'Neill Library at Boston College, where three postgraduate biology students in the Morrissey College of Arts & Sciences shared a belief that the longevity and healthy ageing space lacked thoughtfully designed, research-driven formulations.

What started as academic discussion evolved into years of study, formulation development, and collaboration — culminating in the launch of the company’s first product, AEON™, in 2021.

From the beginning, the goal was clear:

“We wanted our first formulation to reflect the most promising areas of longevity research — bringing together well-studied compounds in a way that was both comprehensive and synergistic.”
— Prof. Michael Morgan

AEON™ was designed as a comprehensive NAD+ focused formulation, with each compound selected for its individual scientific relevance as well as its role within a broader system.

Rather than investing heavily in large-scale advertising campaigns, Perpetua Life® focuses resources on formulation quality, manufacturing standards, and ongoing research review — aiming to provide informed consumers with thoughtfully developed longevity-focused products.

Perpetua Life® UK is a registered company in the United Kingdom (Company No. 14701618) and is responsible for distribution of Perpetua Life® products within the UK and selected international markets.